Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells

Gene Therapy

Volumn 18, Issue 3, 2011, Pages 220-224

  Zhao, N ^a   Fogg, J M ^b   Zechiedrich, L ^b   Zu, Y ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

anaplastic large cell lymphoma (ALCL); cell transfection; DNA minicircle; gene silencing

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; NUCLEIC ACID; PLASMID DNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ADHESION; ARTICLE; BASE PAIRING; CONTROLLED STUDY; DNA SUPERCOILING; DNA VECTOR; FIBROBLAST; GENE EXPRESSION; GENE SILENCING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOMA CELL; PRIORITY JOURNAL; PROMOTER REGION;

CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MUTAGENESIS, SITE-DIRECTED; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 79952486101     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.123     Document Type: Article

References (31)

1. Kim B, Tang Q, Biswas PS, Xu J, Schliffelers RM, Xie FY et al. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol 2004; 165: 2177-2185. (Pubitemid 39578394)
2. Haussecker D, Cao D, Huang Y, Parameswaran P, Fire AZ, Kay MA. Capped small RNAs and MOV10 in human hepatitis delta virus replication. Nat Struct Mol Biol 2008; 15: 714-721. (Pubitemid 351932001)
3. Shi Y. Mammalian RNAi for the masses. Trends Genet 2003; 19: 9-12. (Pubitemid 35472172)
4. Taroncher-Oldenburg G, Marshall A. Trends in biotech literature 2006. Nat Biotechnol 2007; 25: 961.
5. Kurreck J. RNA interference: from basic research to therapeutic applications. Angew Chem Int Ed Engl 2009; 48: 1378-1398.
6. Anonymous. Gene therapy deserves a fresh chance. Nature 2009; 461: 1173.
7. Ma HT, On KF, Tsang YH, Poon RY. An inducible system for expression and validation of the specificity of short hairpin RNA in mammalian cells. Nucleic Acids Res 2007; 35: e22.
8. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553. (Pubitemid 34408678)
9. Bigger BW, Tolmachov O, Collombet JM, Fragkos M, Palaszewski I, Coutelle. An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. J Biol Chem 2001; 276: 23018-23027.
10. Swartz MN, Trautner TA, Kornberg A. Enzymatic synthesis of deoxyribonucleic acid. XI. Further studies on nearest neighbor base sequences in deoxyribonucleic acids. J Biol Chem 1962; 237: 1961-1967.
11. Chen ZY, He CY, Meuse L, Kay MA. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Therapy 2004; 11: 856-864. (Pubitemid 38714589)
12. Darquet AM, Cameron B, Wils P, Scherman D, Crouzet J. A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Therapy 1997; 4: 1341-1349. (Pubitemid 28004593)
13. Yew NS, Zhao H, Przbylska M, Wu IH, Tousignant JD, Scheule RK et al. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol Ther 2002; 5: 731-738. (Pubitemid 34619066)
14. Reyes-Sandoval A, Ertl HC. CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses. Mol Ther 2004; 9: 249-261. (Pubitemid 38256551)
15. Chen ZY, He CY, Ehrhardt A, Kay MA. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 2003; 8: 495-500. (Pubitemid 37161471)
16. Mamanova L, Andrews RM, James KD, Sheridan EM, Ellis PD, Langford CF et al. FRT-seq: amplification-free, strand-specific transcriptome sequencing. Nat Methods 2010; 7: 130-132.
17. Kreiss P, Cameron B, Rangara R, Mailhe P, Aguerre-Charriol O, Airiau M et al. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res 1999; 27: 3792-3798. (Pubitemid 29454426)
18. Yin W, Xiang P, Li Q. Investigations of the effect of DNA size in transient transfection assay using dual luciferase system. Anal Biochem 2005; 346: 289-294. (Pubitemid 41550259)
19. Fogg JM, Kolmakova N, Rees I, Magonov S, Hansma H, Perona JJ et al. Exploring writhe in supercoiled minicircle DNA. J Phys Condens Matter 2006; 18: S145-S159.
20. Bednar J, Furrer P, Stasiak A, Dubochet J, Egelman EH, Bates AD. The twist, writhe and overall shape of supercoiled DNA change during counterion-induced transition from a loosely to a tightly interwound superhelix. Possible implications for DNA structure in vivo. J Mol Biol 1994; 235: 825-847.
21. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281-1284. (Pubitemid 24107549)
22. Ladanyi M. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma. Cancer Surv 1997; 30: 59-75. (Pubitemid 27371536)
23. Piva R, Chiarle R, Manazza AD, Taulli R, Simmons W, Ambrogio C et al. Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood 2006; 107: 689-697. (Pubitemid 43076395)
24. Amin HM, Lai R. Pathobiology of ALK+anaplastic large-cell lymphoma. Blood 2007; 110: 2259-2267.
25. Ritter U, Damm-Welk C, Fuchs U, Bohle RM, Borkhardt A, Woessmann W. Design and evaluation of chemically synthesized siRNA targeting the NPM-ALK fusion site in anaplastic large cell lymphoma (ALCL). Oligonucleotides 2003; 13: 365-373. (Pubitemid 38404821)
26. Hsu FY, Zhao Y, Anderson WF, Johnston PB. Down regulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro. Cancer Invest 2007; 25: 240-248. (Pubitemid 47026946)
27. Marzec M, Kasprzcka M, Ptasznik A, Wlodarski P, Zhang Q, Odum N etal. Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3. Lab Invest2005; 85: 1544-1554. (Pubitemid 41662338)
28. Poluri A, Sutton RE. Titers of HIV-based vectors encoding shRNAs are reduced by a dicer-dependent mechanism. Mol Ther 2008; 16: 378-386. (Pubitemid 351168047)
29. Tiscornia G, Singer O, Ikawa M, Verma IM. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA 2003; 100: 1844-1848. (Pubitemid 36254536)
30. Ito M, Zhao N, Zeng Z, Chang CC, Zu Y Synergistic inhibition of anaplastic large cell lymphoma cells by combining cellular ALK gene silencing and a low dose of the kinase inhibitor U0126. Cancer Gene Ther 2010; 17: 633-644.
31. Zechiedrich EL, Khodursky AB, Cozzarelli NR. Topoisomerase IV, not gyrase, decate-nates products of site-specific recombination in Escherichia coli. Genes Dev 1997; 11: 2580-2592. (Pubitemid 27438838)